Correlation Between Kronos Bio and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and InMed Pharmaceuticals, you can compare the effects of market volatilities on Kronos Bio and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and InMed Pharmaceuticals.
Diversification Opportunities for Kronos Bio and InMed Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Kronos and InMed is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Kronos Bio i.e., Kronos Bio and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kronos Bio and InMed Pharmaceuticals
Given the investment horizon of 90 days Kronos Bio is expected to generate 0.47 times more return on investment than InMed Pharmaceuticals. However, Kronos Bio is 2.12 times less risky than InMed Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 92.00 in Kronos Bio on December 26, 2024 and sell it today you would lose (5.81) from holding Kronos Bio or give up 6.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Kronos Bio vs. InMed Pharmaceuticals
Performance |
Timeline |
Kronos Bio |
InMed Pharmaceuticals |
Kronos Bio and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kronos Bio and InMed Pharmaceuticals
The main advantage of trading using opposite Kronos Bio and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.Kronos Bio vs. Day One Biopharmaceuticals | Kronos Bio vs. Mirum Pharmaceuticals | Kronos Bio vs. Rocket Pharmaceuticals | Kronos Bio vs. Avidity Biosciences |
InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |